CM
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Capital World Investors
· Reduced
−$778M
Change
−21.0M
Date
Q1 2026
|
Capital World Investors | Reduced· Q1 2026 | −$778M | −21.0M | – | Q1 2026 | |||||
|
Norges
· Exited
−$712M
Change
−19.2M
Δ Own
−100.0%
Date
Q1 2026
|
Norges | Exited· Q1 2026 | −$712M | −19.2M | −100.0% | Q1 2026 | |||||
|
Vanguard
· Added
+$536M
Change
+14.5M
Date
Q1 2026
|
Vanguard | Added· Q1 2026 | +$536M | +14.5M | – | Q1 2026 | |||||
|
Alliancebernstein L.P.
· Reduced
−$413M
Change
−11.1M
Date
Q1 2026
|
Alliancebernstein L.P. | Reduced· Q1 2026 | −$413M | −11.1M | – | Q1 2026 | |||||
|
D. E. Shaw & Co., Inc.
· Added
+$365M
Change
+9.9M
Δ Own
+218.9%
Date
Q1 2026
|
D. E. Shaw & Co., Inc. | Added· Q1 2026 | +$365M | +9.9M | +218.9% | Q1 2026 | |||||
|
Goldman Sachs Group Inc
· Added
+$352M
Change
+9.5M
Date
Q1 2026
|
Goldman Sachs Group Inc | Added· Q1 2026 | +$352M | +9.5M | – | Q1 2026 | |||||
|
FMR LLC
· Added
+$262M
Change
+7.1M
Δ Own
+30.4%
Date
Q1 2026
|
FMR LLC | Added· Q1 2026 | +$262M | +7.1M | +30.4% | Q1 2026 | |||||
|
Bank of America Corp
· Added
+$205M
Change
+5.5M
Date
Q1 2026
|
Bank of America Corp | Added· Q1 2026 | +$205M | +5.5M | – | Q1 2026 | |||||
|
Two Sigma Investments, LP
· Added
+$205M
Change
+5.5M
Δ Own
+205.9%
Date
Q1 2026
|
Two Sigma Investments, LP | Added· Q1 2026 | +$205M | +5.5M | +205.9% | Q1 2026 | |||||
|
Morgan Stanley
· Reduced
−$188M
Change
−5.1M
Date
Q1 2026
|
Morgan Stanley | Reduced· Q1 2026 | −$188M | −5.1M | – | Q1 2026 | |||||
|
Citadel Advisors LLC
· Reduced
−$176M
Change
−4.7M
Δ Own
−51.6%
Date
Q1 2026
|
Citadel Advisors LLC | Reduced· Q1 2026 | −$176M | −4.7M | −51.6% | Q1 2026 | |||||
|
Third Point LLC
· Exited
−$175M
Change
−4.7M
Δ Own
−100.0%
Date
Q1 2026
|
Third Point LLC | Exited· Q1 2026 | −$175M | −4.7M | −100.0% | Q1 2026 | |||||
|
T. Rowe Price Associates
· Reduced
−$174M
Change
−4.7M
Date
Q1 2026
|
T. Rowe Price Associates | Reduced· Q1 2026 | −$174M | −4.7M | – | Q1 2026 | |||||
|
UBS Group AG
· Added
+$162M
Change
+4.4M
Date
Q1 2026
|
UBS Group AG | Added· Q1 2026 | +$162M | +4.4M | – | Q1 2026 | |||||
|
Ilex Capital Partners (uk) LLP
· New
+$148M
Change
+4.0M
Date
Q1 2026
|
Ilex Capital Partners (uk) LLP | New· Q1 2026 | +$148M | +4.0M | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Winston Mary A.
· Director
Grant (A)
$215K
|
Winston Mary A. | Director | Grant (A) | $31.25 | 7K | $215K | 38K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Weinstein Joshua Ian
· Director
Grant (A)
$215K
|
Weinstein Joshua Ian | Director | Grant (A) | $31.25 | 7K | $215K | 10K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Maw Scott Harlan
· Director
Grant (A)
$215K
|
Maw Scott Harlan | Director | Grant (A) | $31.25 | 7K | $215K | 49K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Hickenlooper Robin S.
· Director
Grant (A)
$215K
|
Hickenlooper Robin S. | Director | Grant (A) | $31.25 | 7K | $215K | 50K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Gutierrez Mauricio
· Director
Grant (A)
$215K
|
Gutierrez Mauricio | Director | Grant (A) | $31.25 | 7K | $215K | 42K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Fuentes Laura
· Director
Grant (A)
$215K
|
Fuentes Laura | Director | Grant (A) | $31.25 | 7K | $215K | 18K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Filikrushel Patricia
· Director
Grant (A)
$215K
|
Filikrushel Patricia | Director | Grant (A) | $31.25 | 7K | $215K | 43K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Carey Matt
· Director
Grant (A)
$215K
|
Carey Matt | Director | Grant (A) | $31.25 | 7K | $215K | 67K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Baldocchi Albert S.
· Director
Grant (A)
$215K
|
Baldocchi Albert S. | Director | Grant (A) | $31.25 | 7K | $215K | 862K | – | Jun 11, 2026 | Jun 12, 2026 | |||||||||
|
Baldocchi Albert S.
· Director
Gift (G)
-7K
|
Baldocchi Albert S. | Director | Gift (G) | – | -7K | – | 855K | – | May 20, 2026 | May 21, 2026 | |||||||||
|
Filikrushel Patricia
· Director
Sell
−$123K
|
Filikrushel Patricia | Director | Sell | $36.58 | −3K | −$123K | 36K | – | Feb 24, 2026 | Feb 25, 2026 | |||||||||
|
Schalow Laurie
· Officer
Tax withholding or exercise payment (F)
-$1.3M
|
Schalow Laurie | Officer | Tax withholding or exercise payment (F) | $35.84 | -37K | -$1.3M | 197K | – | Feb 15, 2026 | Feb 17, 2026 | |||||||||
|
Schalow Laurie
· Officer
Grant (A)
77K
|
Schalow Laurie | Officer | Grant (A) | – | 77K | – | 234K | – | Feb 15, 2026 | Feb 17, 2026 | |||||||||
|
Rymer Adam T.
· CFO
Tax withholding or exercise payment (F)
-$322K
|
Rymer Adam T. | CFO | Tax withholding or exercise payment (F) | $35.84 | -9K | -$322K | 93K | – | Feb 15, 2026 | Feb 17, 2026 | |||||||||
|
Rymer Adam T.
· CFO
Grant (A)
26K
|
Rymer Adam T. | CFO | Grant (A) | – | 26K | – | 102K | – | Feb 15, 2026 | Feb 17, 2026 | |||||||||
1,277 reporting institutions disclosed CMG position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.